European Medical Solutions (STU:AS00) LT-Debt-to-Total-Asset: 0.20 (As of Dec. 2025)

What is European Medical Solutions LT-Debt-to-Total-Asset?

European Medical Solutions STU:AS00 +0.43% 51 LT-Debt-to-Total-Asset is 0.20 as of Dec. 2025. GuruFocus rates STU:AS00 with a GF Score™ of 51/100 and a GF Value™ of €8.11. The stock has 2 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. European Medical Solutions's long-term debt to total assests ratio for the quarter that ended in Dec. 2025 was 0.20.

European Medical Solutions's long-term debt to total assets ratio declined from Dec. 2024 (0.26) to Dec. 2025 (0.20). It may suggest that European Medical Solutions is progressively becoming less dependent on debt to grow their business.

European Medical Solutions (STU:AS00) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

European Medical Solutions LT-Debt-to-Total-Asset Related Terms

European Medical Solutions LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for European Medical Solutions's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

European Medical Solutions LT-Debt-to-Total-Asset Chart

European Medical Solutions Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.25

0.27

0.30

0.26

0.20

European Medical Solutions Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.30	0.26	0.26	0.19	0.20

51GF Score

European Medical Solutions STU:AS00

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

European Medical Solutions LT-Debt-to-Total-Asset Calculation

European Medical Solutions's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )	/	Total Assets (A: Dec. 2025 )
	=	10.169	/	51.79
	=	0.20

European Medical Solutions's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (Q: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2025 )	/	Total Assets (Q: Dec. 2025 )
	=	10.169	/	51.79
	=	0.20

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.20 mean?

European Medical Solutions (STU:AS00) has a LT-Debt-to-Total-Asset of 0.20 as of Dec. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on European Medical Solutions and its competitors.

Is European Medical Solutions' LT-Debt-to-Total-Asset too high?

European Medical Solutions' current LT-Debt-to-Total-Asset is 0.20. Overall, European Medical Solutions has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.

How does European Medical Solutions' LT-Debt-to-Total-Asset compare to VRTX and REGN?

European Medical Solutions' LT-Debt-to-Total-Asset of 0.20 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Biotechnology company?

A good LT-Debt-to-Total-Asset depends on the Biotechnology industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on European Medical Solutions and its competitors. European Medical Solutions's current LT-Debt-to-Total-Asset is 0.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is European Medical Solutions stock overvalued right now?

European Medical Solutions (STU:AS00) has a current LT-Debt-to-Total-Asset of 0.20. The stock's GF Value™ is €8.11, compared to a current price of €4.72 — trading 41.8% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.20. European Medical Solutions' overall GF Score™ is 51/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For European Medical Solutions (STU:AS00), the current LT-Debt-to-Total-Asset is 0.20 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is European Medical Solutions (STU:AS00) Overvalued in 2026?

Based on GuruFocus' analysis, European Medical Solutions stock appears to be undervalued. The current stock price of €4.72 is trading 41.8% below its estimated GF Value™ of €8.11.

Key valuation signals for STU:AS00:

LT-Debt-to-Total-Asset: 0.20
GF Value™: €8.11 vs. price of €4.72 (41.8% below fair value)
GF Score™: 51/100 with 2 warning signs

No single metric tells the full story. See the STU:AS00 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

European Medical Solutions Business Description

Industry Healthcare Biotechnology

Comparable Companies XBRU:CYAD XBRU:OXUR VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA XKRX:068270 RPRX ROIV BNTX INCY INSM HKSE:02269 ASND

Other Exchanges ALEMS:Belgium

Address 7 Rue des Chasseurs Ardennais, Liege, BEL, 4031

Website https://www.dms-imaging.com

European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.

51GF Score

Get the complete analysis for STU:AS00

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.72

Price

€8.11

GF Value

View STU:AS00 Analysis

See LT-Debt-to-Total-Asset data for all stocks →